SCHEMBL1888261

SCHEMBL1888261

CCC(N)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12261602 1.00
SCHEMBL3465862 1.00
Hydrochloric Acid SCHEMBL4472643 0.98 ALOX5 (0.40)
Hydrochloric Acid SCHEMBL15476689 0.98 ALOX5 (0.40)
Oxalic Acid SCHEMBL1535381 0.89 ALOX5 (0.45)
Acrylic Acid SCHEMBL1199176 0.83 ALOX5 (0.41)
SCHEMBL4444118 0.83 ALOX5 (0.42)
SCHEMBL23695275 0.80 CA2 (0.43)
SCHEMBL5796511 0.80
SCHEMBL15765746 0.79 ALOX5 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119601387-A Preparation method and application of sulfur/nitrogen doped ordered mesoporous carbon material 福建省鑫森炭业股份有限公司 2025-03-11 CN claimed
CN-119569947-A In-chain functionalized solution polymerized styrene-butadiene rubber and in-chain modification method thereof 中哲(浙江)高分子新材料有限公司 2025-03-07 CN claimed
EP-3658550-A1 NEW PROPANAMINE DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-06-03 EP claimed
WO-2019020792-A1 NEW PROPANAMINE DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS ESTEVE PHARMACEUTICALS, S.A. (ES) 2019-01-31 WO claimed
CN-119601387-A Preparation method and application of sulfur/nitrogen doped ordered mesoporous carbon material 福建省鑫森炭业股份有限公司 2025-03-11 CN disclosed
US-12152014-B2 Therapeutic compounds and compositions eXlthera Pharmaceuticals, Inc. (US) 2024-11-26 US disclosed
CN-112748649-B Toner for developing electrostatic charge image, toner storage unit, image forming apparatus, and image forming method 株式会社理光 2024-11-01 CN disclosed
US-20240059670-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS Cadrenal Therapeutics, Inc. 2024-02-22 US disclosed
CN-117120941-A Cleaning blade, image forming apparatus, and process cartridge 株式会社理光 2023-11-24 CN disclosed
CN-108170011-B Toner set, white toner, developer, toner cartridge, process cartridge, image forming apparatus, and image forming method 富士胶片商业创新有限公司 2023-10-03 CN disclosed
CN-116670596-A Image forming apparatus 株式会社理光 2023-08-29 CN disclosed
US-11691962-B2 Therapeutic compounds and compositions EXITHERA PHARMACEUTICALS, INC. (US) 2023-07-04 US disclosed
WO-2006027798-A2 A PROCESS FOR PREPARATION OF AN ANTIDEPRESSANT COMPOUND SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2006-03-16 WO disclosed
CN-1428145-A Quinoline derivative as tachykinin NK3 receptor agonist SMITHKLINE BEECHEM CORP (IT) 2003-07-09 CN disclosed
US-6348435-B1 Substituted 2,4-diamino-1,3,5-triazine and their use as herbicides BAYER AKTIENGESELLSCHAFT (DE) 2002-02-19 US disclosed
CN-1276211-A Use of non-peptides NK3-antagonist SMITHKINE BEECHEM S P A (IT) 2000-12-13 CN disclosed
EP-1021441-A1 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINE AND THEIR USE AS HERBICIDES BAYER AG (DE) 2000-07-26 EP disclosed
WO-1999018100-A1 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINE AND THEIR USE AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1999-04-15 WO disclosed
CN-1157282-A Dehdyration of ion-exchange resin catalyzed reactions GEN ELECTRIC (US) 1997-08-20 CN disclosed
US-4242474-A A POLYHYDROXY ACRYLIC ESTER REACTED WITH AN ISOCYANATE TERMINATED POLYOXYALKYLENE GLYCOL; BIOPOLYMERS TERUMO CORPORATION (JP) 1980-12-30 US disclosed